ASCO 2019: Proteomics analysis discovers biomarkers in serum months to years before small cell lung cancer

Oluf Dimitri Røe | ASCO 2019 | 4. Juni 2019

Speaker: Oluf Dimitri Røe

This is one of the first large-scale proteomics screening studies of pre-diagnostic serum of future small-cell lung cancer (SCLC) patients The results indicate that differential levels of a few proteins in serum may help detecting SCLC 2 months to 5 years prior to clinical diagnosis.